Manila Times Business
TME Pharma Signs Binding Exclusive Negotiation Agreement with Japanese TMS Co., Ltd.
TME Pharma Signs Binding Exclusive Negotiation Agreement with Japanese TMS Co., Ltd. TME Pharma receives €150,000 for 6 months of exclusivity to negotiate a definitive agreement for worldwide rights to NOX-A12TMS Co., Ltd., a Japanese clinical stage biotechnology company, to establish a subsidiary ("Subsidiary”) to facilitate the financing and further clinical development of NOX-A12Non-binding terms negotiated as basis for further discussions. According to these terms, TME Pharma to receive the
This is an excerpt. Read the full article at the original source:
Source: manilatimes.net
Read Full Article on manilatimes.net →More from Manila Times Business
Global Times: Long March spirit sails on in China’s modern navy, spurs innovation and self-reliance
4h ago
Keeping Classics Alive and Evolving: 2026 iCAUR International User Summit Concludes with New Advances in Future Classic Design and Customization Ecosystem
4h ago
South Carolina police close investigation into Hayden Panettiere's death
4h ago
Debate on California’s Prop 40 Wealth Tax Backfiring is Topic of Latest Family Enterprise USA ‘Family Business Briefs’ Podcast
5h ago